Human Siglec-2/CD22 LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

Llama Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
LMAB107321S	R&D Systems LMAB107321SP	25 μg
LMAB1073211	R&D Systems LMAB107321100	100 μg

Description

Siglec-2/CD22 Monoclonal antibody specifically detects Siglec-2/CD22 in Human samples. It is validated for Immunocytochemistry

Specifications

• Antigen: Siglec-2/CD22
• Dilution: Immunocytochemistry 8-25 ug/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Gene Alias: B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14
• Immunogen: Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

• Clone: L007.2.5H
• Applications: Immunocytochemistry
• Conjugate: Unconjugated
• Host Species: Llama
• Target Species: Human
• Gene Accession No.: CAA42006.1
• Gene ID (Entrez): 933
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.